Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound

Trading after the bell was relatively muted on Thursday, with small-cap biotech names showing modest shifts. Delcath Systems edged higher following its buyback announcement, while BioVie, Cassava Sciences, and Enlivex Therapeutics rebounded despite a lack of fresh headlines.Delcath Systems, Inc. (DCTH) rose in after-hours trading to $8.52, up 4.02% or $0.33. Earlier in the day, the stock had closed at $8.19, down 3.76% or $0.32. The rebound followed the company's announcement of a $25 million share repurch ...